|
|
Study on the effect and mechanism of Mongolian medicine Sirixi in preventing and treating experimental gastric ulcer |
Aodengqimuge WANG Hairong Wuhanqimuge Tegexibaiyin |
Innovative Mongolian Pharmaceutical Preparation Engineering Laboratory, Inner Mongolia International Mongolian Hospital, Inner Mongolia Autonomous Region, Hohhot 010065, China |
|
|
Abstract Objective To study the preventive and therapeutic effect of Mongolian medicine Sirixi on gastric ulcer and its possible mechanism. Methods A total of 25 Wistar rats were selected to make rat acute gastric ulcer model induced by indomethacin. Changes of gastric mucosa were observed by hematoxylin-eosin staining. A total of 25 Kunming mice were selected to observe the changes of myeloperoxidase (MPO) activity, glutathione (GSH) level and peripheral blood T lymphocyte level in gastric tissues in the ethanol/HCL-induced acute gastric ulcer model. A total of 20 Wistar rats were selected and the expression levels of inflammatory tumor necrosis factor-α (TNF-α) and intercellular adhesion molecule 1 (ICAM-1) in gastric tissues were determined by enzyme-linked immunosorbent assay in a acetic acid-burning chronic gastric ulcer model. Results Compared with the model group, the gastric mucosal lesions were alleviated in the Sirixi Powder group. Compared with the model group, the gastric tissue MPO activity, the expression levels of TNF-α and ICAM-1 in the gastric mucosa of the Sirixi Powder group were decreased, and the expression levels of GSH were increased, the differences were highly statistically significant (all P < 0.01). Compared with the model group, the thymus, spleen weight index and the expression levels of peripheral blood CD4+ cells were increased in the Sirixi Powder group, with statistically significant differences (P < 0.05 or P < 0.01), while there was no significant difference in the expression levels of CD3+, CD4+/CD8+ and CD8+ between the two groups (P > 0.05). Conclusion The mechanism of action of Sirixi Powder in the prevention and treatment of gastric ulcer may be realized by promoting defense factor, inhibiting damage factor and improving immune ability.
|
|
|
|
|
[1] 佟皎薇,夏瑶宾,朱明.蒙药斯日西胶囊质量研究[J].中国民族医药杂志,2007,13(4):59.
[2] 巴特金,苏和,张松波,等.蒙药斯日西散预防脓毒症患者肠内营养胃肠道并发症的疗效观察[J].中国药物与临床,2010,3(10):358.
[3] 哈日巴拉,朱海龙.诊治胃宝日病临床体会[J].中国民族医药杂志,1997,12(3):42-43.
[4] 麻春杰,包·纳日斯,敖其尔.消化性溃疡的蒙医药研究概况[J].中国民族医药杂志,2007,13(9):61-64.
[5] Kuzmich S,Harvey CJ,Fascia DT,et al. Perforated pyloroduodenal peptic ulcer and sonography [J]. AJR Am J Roentgenol,2012,199(5):W587-W594.
[6] Sung JJ,Tsoi KK,Ma TK,et al. Causes of mortalityin patients with peptic ulcer bleeding:a prospective cohort study of 10,428 cases [J]. Am J Gastroenterol,2012,105(1):84-89.
[7] Arakawa T,Higuchi K,Fujiwara Y,et al. Helicobacter pylori:criminal or innocent bystander [J]. J Gastroenterol,2000,35 Suppl 12:42-46.
[8] Jiang GR,Ge HN,Liang GQ,et al. Therapeutic and recurrence-preventing effects of Qi-Replenishing and Blood-Activating Formula in rats with acetic acid-induced gastric ulcer [J]. Asian Pac J Trop Med,2016,9(1):81-85.
[9] Gisbert JP,Calvet X,Cosme A,et al. Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding [J]. Am J Gastroenterol,2012,107(8):1197-1204.
[10] 周晓伟,张雨,徐瑞明,等.楹树提取物对大鼠醋酸型慢性胃溃疡的治疗作用及抗炎机制[J].国际药学研究杂志,2017,44(7):699-706.
[11] Aga H,Readhead D,Maccoll G,et al. Fall in peptic ulcer mortality associated with increased consultant input,prompt surgery and use of high dependency care identified through peer-review audit2012 [J]. BMJ Open,2012, 2(1): e000271.
[12] 朱斌,李娜,陈晴,等.养胃颗粒对实验性胃溃疡的治疗作用研究[J].药学实践杂志,2018,36(5):438-442,452.
[13] 施慧.白果内酯对胃溃疡的保护作用及其机制研究[D].广州:南方医科大学,2017.
[14] de Barros M,Mota da Silva L,Boeing T,et al. Pharmacological reports about gastroprotective effects of methanolic extract from leaves of Solidago chilensis(Brazilian arnica)and its components quercitrin and afzelin in rodents [J]. Send to Naunyn Schmiedebergs Arch Pharmacol,2016, 389(4):403-417.
[15] 唐梅文,黄勇华,陈国忠,等.七方胃痛颗粒对PU患者T淋巴细胞亚群与TNF-α的影响[J].广西医科大学学报,2010,27(1):90-91.
[16] 张玉泉,李茂清,徐碧虹.康胃愈溃汤Ⅱ号对老年消化性溃疡外周血T淋巴细胞亚群及相关炎症因子水平影响的研究[J].新中医,2013,45(2):18-20.
[17] 吴文飞,张建东,单立兵,等.奥美拉唑联合铝碳酸镁对急诊胃溃疡患者疗效及CD4+、CRP、CD8+的影响分析[J].中国医药科学,2019,9(21):49-52.
[18] 宾金秀,梁雪.中医药提高消化性溃疡愈合质量机制的研究进展[J].广西中医药大学学报,2015,18(2):77-79.
[19] 齐东江,徐阿曼.奥美拉唑对小鼠胸腺、脾脏免疫功能的影响[J].安徽医药.2015,19(9):1665-1667.
[20] 通拉嘎,梅红,其木格,等.大鼠乙酸型胃溃疡模型的建立与评价[J].中国民族民间医药,2017,26(11):49-51,55.
[21] 马麟,张昕,陈焕鑫,等.沉香提取液对乙醇致大鼠胃溃疡的保护作用及机制[J].中国医药导报,2019,16(24):15-18.
[22] 沈艳婷,阙任烨,陶智会,等.纳达合剂对胆汁反流性胃炎大鼠胃黏膜TNF-α、IL-8、ICAM-1及MCP-1的影响[J].上海中医药大学学报,2015,29(6):55-59,63. |
|
|
|